New hope for leukemia patients: drug combo shows promise in early trial
NCT ID NCT04742101
First seen May 24, 2026 · Last updated May 24, 2026
Summary
This study tested a new drug called S65487 combined with azacitidine in 57 adults with untreated acute myeloid leukemia who were not healthy enough for intensive treatment. The goal was to see if the combination is safe and can help achieve complete remission. The trial has completed, and results will show how well the treatment works and what side effects occur.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
C. Universidad de Navarra Servicio de Hematologia
Pamplona, 31008, Spain
-
H. Universitario La Fe Servicio de Hematologia
Valencia, 46026, Spain
-
Hospital 12 de Octubre Servicio de Hematología
Madrid, 28041, Spain
-
Institut Gustave Roussy
Villejuif, 94805, France
-
Narodowy Instytut Onkologii im. M. Sklodowskiej-Curie Klinika Transplantacji Szpiku i Onkohematologii pokoj 4.041 ul. Wybrzeze Armii Krajowej 15
Gliwice, 44-102, Poland
-
Samsung Medical Center - Division of Hematology-Oncology
Seoul, 06351, South Korea
-
Semmelweis Egyetem Belgyógyászati és Onkológiai Klinika Klinikai Farmakológiai Részleg
Budapest, H-1083, Hungary
-
Seoul National University Hospital - Department of Hematology-Oncology
Seoul, 03080, South Korea
-
The Christie NHS foundation Trust
Manchester, M20 4BX, United Kingdom
-
University College London - Hospitals NHS Foundation Trust
London, NW1 2PG, United Kingdom
-
Western General Hospital
Edinburgh, EH4 2XU, United Kingdom
Conditions
Explore the condition pages connected to this study.